NEW LEAF BIOPHARMA OPPORTUNITIES II, L.P. purchased 1.54M shares of HARPOON THERAPEUTICS, INC. on the open market
Open‑market purchases signal personal conviction.
P · 2 purchases
Filed: 10/27/2023ACC: 0000899243-23-020044
→
10% Owner
Since Feb 2019
+2.32M
Net shares
Net buyer
$0.00
Total acquired
2
Open market trades
2B · 0S
4
Total transactions
2.32M acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+1.37M
Price / share
—
Trade value
—
% of position
1501.3%
10/25/2023
91.39K→1.46M
Common Stock
Indirect
Shares
+171.50K
Price / share
—
Trade value
—
% of position
76.5%
10/25/2023
224.28K→395.78K
Total
Net shares
+1.54M
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/25/2023 | P · Purchase | +1.37M | — | — | 1501.3% | 91.39K | 1.46M |
| Common Stock Indirect | 10/25/2023 | P · Purchase | +171.50K | — | — | 76.5% | 224.28K | 395.78K |
| Total | +1.54M | $0.00 | ||||||
Derivative Transactions2
Common Stock Warrant (Right to Buy)
Direct
Converts to
Common Stock
686K shares
Shares
+686K
Strike price
5.8345
Held after
686K
Exercisable
—
10/25/2023
Common Stock Warrant (Right to Buy)
Indirect
Converts to
Common Stock
85.75K shares
Shares
+85.75K
Strike price
5.8345
Held after
85.75K
Exercisable
—
10/25/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Common Stock Warrant (Right to Buy) Direct | Common Stock686K shares | 10/25/2023 | P · Purchase | +686K | 5.8345 | — | 686K |
| Common Stock Warrant (Right to Buy) Indirect | Common Stock85.75K shares | 10/25/2023 | P · Purchase | +85.75K | 5.8345 | — | 85.75K |
Non-Derivative Holdings (Post-Transaction)1
8.000% Series A Redeemable Preferred Stock
DirectShares owned10K
Total
10K direct10K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| 8.000% Series A Redeemable Preferred Stock | 10K | Direct |
| Total | 10K | 10K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported